Analyst Jeffrey Zekauskas upgraded the stock to overweight from neutral.
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.
Restaurant Brands' revenue climbed 26% in the quarter.
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
Applications to refinance a home loan jumped 10% compared with the previous week and were 33% higher than the same week one year ago.
The U.S. has spent billions rebuilding New Orleans in the aftermath of Hurricane Katrina. Some of the interventions have, at times, had unintended consequences.
Super Micro Computer issued a lofty fiscal 2026 outlook, lifting the stock more than 13%. JPMorgan remains skeptical, however.
The consumer price index was expected to increase 0.3% in January, according to the Dow Jones consensus estimate.
Federal Reserve Chair Jerome Powell returns to Capitol Hill on Wednesday for the second day of his semiannual updates on monetary policy.
Olipop's annual sales surpassed $400 million in 2024, as competition heats up with rivals like Poppi.